ストックスクリーナーアプリを入手
292.35
0.44%
-1.29
プレマーケット:
290.00
-2.35
-0.80%
前日終値:
$293.64
開ける：
$291.32
24時間の取引高:
1.49M
Relative Volume:
1.09
時価総額：
$56.66B
収益：
$310.23B
当期純損益:
$1.69B
株価収益率:
33.92
EPS:
8.62
ネットキャッシュフロー:
$3.58B
1週間 パフォーマンス:
+0.89%
1か月 パフォーマンス:
-1.31%
6か月 パフォーマンス:
+15.43%
1年 パフォーマンス:
+21.18%
1日の値動き範囲:
$290.99
$294.88
1週間の範囲:
$281.84
$294.88
52週間の値動き範囲:
$218.65
$309.35
Cencora Inc Stock (COR) Company Profile
COR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
292.35 | 56.91B | 310.23B | 1.69B | 3.58B | 8.62 |
|
MCK
Mckesson Corporation
|
709.49 | 88.80B | 359.05B | 3.30B | 5.23B | 25.83 |
|
CAH
Cardinal Health Inc
|
158.24 | 37.86B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
64.83 | 8.75B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.73 | 681.98M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-09-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2023-01-31 | 再開されました | Evercore ISI | Outperform |
| 2022-10-11 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-07-11 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-04-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | 再開されました | Evercore ISI | In-line |
| 2021-02-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-02-02 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-01-06 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-01-06 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 開始されました | Mizuho | Neutral |
| 2020-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 開始されました | Barclays | Underweight |
| 2020-06-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 再開されました | Credit Suisse | Outperform |
| 2020-04-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-03-17 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-11 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-07-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 開始されました | Guggenheim | Buy |
| 2019-04-10 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-02-11 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2018-10-26 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 開始されました | Berenberg | Buy |
| 2018-07-17 | 再開されました | Stifel | Hold |
| 2018-04-09 | 開始されました | MoffettNathanson | Buy |
| 2018-03-12 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 開始されました | JP Morgan | Neutral |
| 2017-09-22 | 開始されました | William Blair | Outperform |
すべてを表示
Cencora Inc (COR) 最新ニュース
Cencora Q3 2025 slides: U.S. segment drives 19.8% EPS growth, guidance raised - Investing.com Nigeria
Cencora Reports Strong Q3 2025 Financial Results - TipRanks
Cencora beats Q3 expectations, raises full-year earnings outlook - Investing.com
Cencora Inc earnings beat by $0.16, revenue topped estimates - Investing.com South Africa
Cencora Earnings Soar Past Estimates as Healthcare Giant Boosts 2025 Profit Outlook - Stock Titan
Cencora's $440M Volume Surge Ranks 281st Amid 0.44% Drop as Liquidity-Driven Gains Outpace Market - AInvest
Mallinckrodt Names Leslie Donato to Board of Directors - BioSpace
Cencora & The Lash Group reach $40M settlement in data breach class action - Claim Depot
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results? - Yahoo Finance
What institutional investors are buying Cencora Inc. stockBuild wealth steadily with proven investment techniques - Jammu Links News
What catalysts could drive Cencora Inc. stock higher in 2025Maximize returns with disciplined trading - Jammu Links News
Should I hold or sell Cencora Inc. stock in 2025Invest in stocks with strong fundamentals - Jammu Links News
How volatile is Cencora Inc. stock compared to the marketInvest confidently with professional market insights - Jammu Links News
What are the latest earnings results for Cencora Inc.Capitalize on market shifts before others do - Jammu Links News
Cencora Inc. Stock Analysis and ForecastOutperformance with explosive growth - Jammu Links News
What makes Cencora Inc. stock price move sharplyHigh-impact investment strategies - Jammu Links News
How does Cencora Inc. compare to its industry peersCapitalize on market trends with confidence - Jammu Links News
How does Cencora Inc. generate profit in a changing economyUnlock daily market insights for better trades - Jammu Links News
How many analysts rate Cencora Inc. as a “Buy”Invest smarter with actionable stock recommendations - Jammu Links News
What analysts say about Cencora Inc. stockPhenomenal trading returns - Jammu Links News
Is it the right time to buy Cencora Inc. stockDiscover market opportunities with expert help - Jammu Links News
What markets is MKC.V expanding into Is Cencora Inc. stock a good long term investment optionBuild a portfolio that outperforms the market - Jammu Links News
What are analysts’ price targets for Cencora Inc. in the next 12 monthsHigh-profit stock alerts - Jammu Links News
What are Cencora Inc. company’s key revenue driversConsistent triple returns - Jammu Links News
What markets is Cencora Inc. expanding into Is VBTX stock a good long term investment optionAccelerated financial growth - Jammu Links News
Should you wait for a breakout in Cencora Inc.Fast Exit and Entry Strategy Guide Offered - metal.it
Gear Up for Cencora (COR) Q3 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Cencora’s 350M Dollar Volume and 422nd Trading Rank Highlight Heightened Investor Interest Amid 9.8% Institutional Stake Increase - AInvest
Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Fortune 10 Cencora Partners With LOCK'DIN for Nationwide Distribution | LTNC Stock News - Stock Titan
Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel - Yahoo Finance
Why Cencora Inc. stock is on top investor watchlistsFree Predictions - metal.it
Cencora (NYSE:COR) shareholders have earned a 25% CAGR over the last five years - Yahoo Finance
What drives Cencora Inc. stock priceDynamic capital growth - PrintWeekIndia
What institutions are buying Cencora Inc. stock nowBreakout stock performance - Jammu Links News
How Cencora Inc. stock compares to its top competitorsIs VBTX stock undervalued or overvalued nowRapid wealth multiplication - Jammu Links News
How high can Cencora Inc. stock price go in 2025Fastest-growing stock picks - Jammu Links News
Cencora Inc (COR) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
1.17%
大文字化:
|
ボリューム (24 時間):